Retinopathy News and Research

RSS

Long-term study shows struggle with weight loss in newly diagnosed type 2 diabetics

A register-based study from Finland identified three distinct BMI trajectory groups among patients with newly diagnosed type 2 diabetes. In a four-year follow-up, most patients followed a stable trajectory without much weight change.

4 Apr 2024

Study reveals crucial insights into the ocular effects of Zika virus infection during pregnancy

A groundbreaking study published in the journal iScience presents crucial insights into the ocular effects of Zika virus infection during pregnancy and offers promising avenues for therapeutic intervention.

28 Mar 2024

As AI eye exams prove their worth, lessons for future tech emerge

Christian Espinoza, director of a Southern California drug-treatment provider, recently began employing a powerful new assistant: an artificial intelligence algorithm that can perform eye exams with pictures taken by a retinal camera. It makes quick diagnoses, without a doctor present.

27 Mar 2024

Minocycline fails to slow vision loss in people with dry age-related macular degeneration

The drug minocycline, an antibiotic that also decreases inflammation, failed to slow vision loss or expansion of geographic atrophy in people with dry age-related macular degeneration (AMD), according to a phase II clinical study at the National Eye Institute (NEI), part of the National Institutes of Health.

22 Mar 2024

Study reveals TDP-43 protein's key role in blood vessel formation and integrity

Defects in the blood vessel network of the central nervous system have been linked to early symptoms of neurodegenerative diseases such as Alzheimer's disease and amyotrophic lateral sclerosis (ALS).

13 Mar 2024

For infants born extremely preterm, redirection of care discussions occurred less often for Black and Hispanic infants

Whether the level of care they receive depends on the social status of the mother is a question recently explored in a study that appeared online in JAMA Pediatrics.

12 Mar 2024

Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema

EXN407 is the first topical SRPK1 inhibitor to demonstrate both safety and signals of biological response as monotherapy for these indications.

5 Mar 2024

Investigational protein replacement protects neonatal mice from deadly intestinal disease

Scientists from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago and colleagues found that an investigational protein replacement – recombinant human insulin-like growth factor 1 and its binding protein-3 (rhIGF-1/BP3) – protected neonatal mice from necrotizing enterocolitis (NEC), a deadly intestinal disease that often strikes extremely premature infants.

28 Feb 2024

Red light exposure mitigates blood glucose spikes after meals

Shining a specific frequency of red light on a person's back for 15 minutes can reduce blood sugar levels, according to a new study from City, University of London and UCL.

22 Feb 2024

Red light therapy lowers blood sugar and mitigates glucose spikes

The researchers found that 670 nanometers (nm) of red light stimulated energy production within mitochondria, the tiny powerhouses within cells, leading to increased consumption of glucose. In particular, it led to a 27.7% reduction in blood glucose levels following glucose intake, and it reduced maximum glucose spiking by 7.5%.

20 Feb 2024

Breakthrough $20 million OCT project aims to revolutionize eye health screening

In the United States, more than one-fourth of adults over age 40 have an eye disease, including glaucoma, cataracts or age-related macular degeneration, or a chronic health condition that affects the eyes, such as diabetic retinopathy.

14 Feb 2024

New treatment targeting aging cells could offer lasting relief for diabetic macular edema

Targeting senescent cells in the retina with a BCL-xL inhibitor shows promise as a durable treatment for diabetic macular edema, potentially offering long-term visual function improvements.

8 Feb 2024

Groundbreaking technology shows immense potential for treating ischemic retinopathy

A groundbreaking technology with immense potential in treating ischemic retinopathy in premature infants and diabetic patients has been developed by Professor Byoung Heon Kang and his research team in the Department of Biological Sciences at UNIST, in collaboration with Professor Dong Ho Park's team at Kyungpook National University Hospital. Ischemic retinopathy, characterized by the breakdown of the blood-retinal barrier and abnormal blood vessel growth, often leads to vision impairment and loss.

24 Jan 2024

Innovative diabetes detection method with DiaNet v2, utilizing retinal imaging technology

Innovative diabetes detection method with DiaNet v2, utilizing retinal imaging technology.

22 Jan 2024

Review of traditional treatments and novel nutritional interventions for sickle cell disease

Nutrition-related studies involving sickle cell disease (SCD) patients, particularly those in Africa.

17 Jan 2024

AI exam boosts diabetic eye screening rates in youth

A Johns Hopkins Children's Center study of children and youth with diabetes concludes that so-called autonomous artificial intelligence (AI) diabetic eye exams significantly increase completion rates of screenings designed to prevent potentially blinding diabetes eye diseases (DED).

11 Jan 2024

Retinopathy News and Research

Long-term study shows struggle with weight loss in newly diagnosed type 2 diabetics

Study reveals crucial insights into the ocular effects of Zika virus infection during pregnancy

As AI eye exams prove their worth, lessons for future tech emerge

Minocycline fails to slow vision loss in people with dry age-related macular degeneration

Study reveals TDP-43 protein's key role in blood vessel formation and integrity

For infants born extremely preterm, redirection of care discussions occurred less often for Black and Hispanic infants

Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activity in treatment of diabetic retinopathy and diabetic macular oedema

Investigational protein replacement protects neonatal mice from deadly intestinal disease

Red light exposure mitigates blood glucose spikes after meals

Red light therapy lowers blood sugar and mitigates glucose spikes

Breakthrough $20 million OCT project aims to revolutionize eye health screening

New treatment targeting aging cells could offer lasting relief for diabetic macular edema

Groundbreaking technology shows immense potential for treating ischemic retinopathy

Innovative diabetes detection method with DiaNet v2, utilizing retinal imaging technology

Review of traditional treatments and novel nutritional interventions for sickle cell disease

AI exam boosts diabetic eye screening rates in youth

Bariatric surgery may mitigate the natural history of cognitive decline in people with obesity

Can AI predict diabetic eye disease progression?

Targeted ocular spectroscopy shines new light on retinal health

AI in healthcare: A double-edged sword? Study reveals impact on diagnostic accuracy

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News